Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Mar;78(3):1805-8.
doi: 10.1073/pnas.78.3.1805.

Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

T W Chang et al. Proc Natl Acad Sci U S A. 1981 Mar.

Abstract

OKT3 monoclonal antibody to human T cells inhibits the target cell lysis mediated by allogeneic cytotoxic T cells and the generation of these effector cells in mixed lymphocyte culture. This marked inhibition of cell-mediated lysis is not found with other monoclonal antibodies also reactive with cell surface antigens of human T cells (OKT1, OKT4, OKT5, OKT6, OKT8, and OKT11). OKT3 antibody is mitogenic and this effect appears to require receptor activation in that it occurs at low concentrations (10(-12) M range) of OKT3 antibody, requires intact OKT3 IgG, and is inhibited by a factor(s) in human plasma. By contrast, the inhibition of allogeneic cell-mediated lysis by OKT3 antibody appears to be due to steric hindrance in that it requires higher concentrations of OKT3 antibody (10(-8) M range), Fab fragments retain approximately 10% activity, and inhibition is demonstrable in the presence of human plasma. These findings are consistent with the suggestion that OKT3 antibody reacts with the human T-cell antigen-recognition structure.

PubMed Disclaimer

References

    1. J Exp Med. 1979 Nov 1;150(5):1216-28 - PubMed
    1. Lancet. 1977 Oct 1;2(8040):671-4 - PubMed
    1. J Immunol. 1980 Mar;124(3):1028-33 - PubMed
    1. J Immunol. 1980 Mar;124(3):1237-44 - PubMed
    1. J Immunol. 1980 Jun;124(6):2708-13 - PubMed

LinkOut - more resources